Superior chemotherapeutic efficacy of Amphotericin B in tuftsin-bearing liposomes against Leishmania donovani infection in hamsters

Journal of Drug Targeting

Volumn 10, Issue 1, 2002, Pages 41-45

  Agrawal, Ajay K ^a   Agrawal, A ^a   Pal, A ^a   Guru, P Y ^a   Gupta, C M ^a  

^a PolyMASC Pharmaceuticals plc   (United Kingdom)

Author keywords

Amphotericin B; Hamsters; Leishmania; Liposomes; Tuftsin

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIINFECTIVE AGENT; ANTILEISHMANIAL AGENT; ARGININE; DRUG VEHICLE; LIPOSOME; LYSINE; PROLINE; TETRAPEPTIDE; THREONINE; TUFTSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERANCE; DRUG UPTAKE; ENCAPSULATION; HAMSTER; LEISHMANIA DONOVANI; LEISHMANIASIS; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; CRICETINAE; DRUG CARRIERS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIPOSOMES; MACROPHAGES; MALE; MESOCRICETUS; TUFTSIN;

EID: 0036122606     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10611860290007513     Document Type: Article

References (26)

1. "Tuftsin-bearing liposomes in treatment of macrophage-based infections"
2. "Antibody-bearing liposomes as chloroquinevehicles in treatment of murine malaria"
3. "Functional drug targeting to erythrocytes using antibody-bearing liposomes as drug vehicles"
4. "Enhanced immunomodulatory and prophylactic effect of a synthetic lipopeptide after liposomization against P. berghei infection in mice"
5. "Tissue distribution and antileishmanial activity of liposomised Amphotericin-B in Balb/mice"
6. "Effect of tuftsin on the migration, hemotaxis, and differentiation of macrophages and granulocytes"
7. "Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis"
8. "Liposomal amphotericin B as first line and secondary prophylactic treatment for visceral leishmaniasis in a patient infected with HIV"
9. "Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis"
10. "Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis"
11. "Novel methods for the encapsulation of meglumine antimoniate into liposomes"
12. "Drug targeting in Leishmania infection using tuftsin-bearing liposomes as drug vehicles"
13. "Treatment of visceral leishmaniasis in HIV-infected patients: A randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania study group"
14. "Long-term remission of humanimmunodeficiency virus-associated visceral leishmaniasis after initiation of potent combination antiretroviral treatment: Report of two cases"
15. "Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells"
16. "U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis"
17. "Kala-azar as an AIDS-related opportunistic infection"
18. "Treatment of experimental visceral eishmaniasis in a T-cell-deficient host response to amphotericin B and pentamidine"
19. "Tuftsin-bearing liposomes as drug vehicles in treatment of experimental aspergillosis"
20. "Serum opsonins and liposomes: Their interaction and opsonophagocytosis"
21. "Destruction of Leishmania mexicana amazonensis amastigotes within macrophages by lysosomotropic amino acid esters"
22. "Respiratory burst in peritoneal exudate cells in response to modified tuftsin"
23. "Specific interactions of liposomes with PMN leukocytes upon incorporating tuftsin in their bilayers"
24. "Liposomal amphotericin B"
25. "Involvement of T cells in enhanced resistance to Klebsiella pneumoniae septicemia in mice treated with liposome-encapsulated muramy tripeptide phosphatidylethanolamine or gamma interferon"
26. "A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis"